Baxter Canada

Baxter Canada, founded in 2018, is a significant entity within the Medical Devices & Equipment and Manufacturing sectors. The company specializes in producing critical intravenous products, essential for delivering fluids and drugs to patients. Its product portfolio also encompasses inhalational anaesthetics and solutions for treating end-stage kidney disease, underscoring its commitment to patient care across various medical needs.

Operating with a substantial workforce of 1,000-5,000 employees across 12 locations, Baxter Canada demonstrates considerable operational scale. The company's offerings extend to contract manufacturing services, leveraging its expertise in healthcare product development. Key product areas include renal care, nutrition therapies, and advanced infusion systems, such as the Sigma Spectrum pump, designed for precise medication delivery. For insights into the people driving these innovations, one can explore Meet Baxter Canada's team.

With a reported revenue of $363.0M, Baxter Canada plays a vital role in the North American healthcare landscape. Its strategic focus on essential medical supplies and treatments positions it within a competitive market, alongside global players like its parent company, Baxter, and other medical technology firms. The company's presence in Ontario, Canada, highlights its regional importance and contribution to the Canadian medical industry.